MyChesCo on MSN12d
Madrigal Pharmaceuticals Announces Changes to Board of Directors
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has announced the appointment of Jacqualyn (“Jackie”) Fouse, Ph.D., to its ...
Nasdaq26d
Decoding Madrigal Pharmaceuticals's Options Activity: What's the Big Picture?
High-rolling investors have positioned themselves bullish on Madrigal Pharmaceuticals (NASDAQ:MDGL), and it's important for retail traders to take note. \This activity came to our attention today ...
Benzinga.com27d
Madrigal Pharmaceuticals Stock Price, Quotes and Forecasts
Explore Madrigal Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDGL. Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing ...
Business Insider26d
Madrigal Pharmaceuticals price target raised to $239 from $154 at BofA
BofA raised the firm’s price target on Madrigal Pharmaceuticals (MDGL) to $239 from $154 and keeps an Underperform rating on the shares. The Q4 updates, which included “favorable” two-year OLE data, ...
Madrigal Pharmaceuticals appoints Fouse to its board of directors
Madrigal Pharmaceuticals (MDGL) announced it has appointed Jacqualyn Fouse, Ph.D. to its Board of Directors. Fred Craves, Ph.D. is retiring ...